Literature DB >> 9327734

Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1.

M Richardson1, M De Reske, K Delaney, A Fletch, L H Wilcox, R L Kinlough-Rathbone.   

Abstract

The pathogenesis of atherosclerosis has been related to infection of the arterial wall, but it is not clear whether this occurs before or after the development of lipid-containing lesions. Respiratory bacterial infection increases the expression of vascular cell adhesion molecule-1 (VCAM-1). We therefore examined whether a similar infection would enhance atherosclerosis in New Zealand White rabbits fed chow supplemented by 15% (w/w) egg yolk for 50 days. Rabbits with naturally acquired respiratory infection by Pasteurella multocida, pathogen-free (SPF) animals infected by P. multocida in the laboratory, and age-matched SPF rabbits maintained in a disease-free environment were used. Endothelial cells expressing VCAM-1 in the aorta between intercostal arteries 3 and 5 were identified using anti-VCAM-1 (Rb1/9) and an alkaline-phosphatase-linked secondary antibody and quantified in Häutchen preparations. The remainder of the aorta was stained with Sudan IV to show lipid deposition. The expression of VCAM-1 (mean +/- SEM per 10,000 cells) was 22 +/- 8 (n = 5) in the lipid-fed SPF rabbits, significantly different from that in the lipid-fed rabbits with naturally occurring infection (190 +/- 51 (n = 5)) or from rabbits infected in the laboratory (106 +/- 25 (n = 5)). The extent of Sudanophilia was significantly greater in the naturally infected rabbits (8.3 +/- 1.2%) or infected SPF rabbits (10.3 +/- 1.8%) than in the SPF rabbits (2.7 +/- 0.8%; P < 0.05). Antibiotic treatment in naturally infected rabbits reduced the number of cells expressing VCAM-1 and the extent of the Sudanophilia to baseline levels. Thus, Sudanophilia is enhanced by bacterial infection in rabbits fed egg yolk and is associated with a significant increase in VCAM-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327734      PMCID: PMC1858025     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

Review 1.  Virus receptors: binding, adhesion strengthening, and changes in viral structure.

Authors:  A M Haywood
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

2.  Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

Authors:  K D O'Brien; M D Allen; T O McDonald; A Chait; J M Harlan; D Fishbein; J McCarty; M Ferguson; K Hudkins; C D Benjamin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

3.  The distribution of adhesion molecules in human atherosclerosis.

Authors:  K M Wood; M D Cadogan; A L Ramshaw; D V Parums
Journal:  Histopathology       Date:  1993-05       Impact factor: 5.087

4.  Lysis of human arterial smooth muscle cells infected with herpesviridae by peripheral blood mononuclear cells: implications for atherosclerosis.

Authors:  S K Datta; J J Tumilowicz; J J Trentin
Journal:  Viral Immunol       Date:  1993       Impact factor: 2.257

5.  Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury.

Authors:  H Tanaka; G K Sukhova; S J Swanson; S K Clinton; P Ganz; M I Cybulsky; P Libby
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

6.  Cytomegalovirus DNA in arterial walls of patients with atherosclerosis.

Authors:  J L Melnick; C Hu; J Burek; E Adam; M E DeBakey
Journal:  J Med Virol       Date:  1994-02       Impact factor: 2.327

7.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

Authors:  C C Kuo; A Shor; L A Campbell; H Fukushi; D L Patton; J T Grayston
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

Review 8.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

9.  Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits.

Authors:  M Richardson; S J Hadcock; M DeReske; M I Cybulsky
Journal:  Arterioscler Thromb       Date:  1994-05

10.  Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells.

Authors:  D D Sedmak; D A Knight; N C Vook; J W Waldman
Journal:  Transplantation       Date:  1994-12-27       Impact factor: 4.939

View more
  6 in total

Review 1.  Activation and resolution of periodontal inflammation and its systemic impact.

Authors:  Hatice Hasturk; Alpdogan Kantarci
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

2.  Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis.

Authors:  Hatice Hasturk; Rima Abdallah; Alpdogan Kantarci; Daniel Nguyen; Nicholas Giordano; James Hamilton; Thomas E Van Dyke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-19       Impact factor: 8.311

3.  Chlamydia pneumoniae and Cardiovascular Disease.

Authors:  Maria Kolia; Ignatius William Fong
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

4.  Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model.

Authors:  Ignatius W Fong; Brian Chiu; Esther Viira; Dan Jang; James B Mahony
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Serological response to Pasteurella multocida NanH sialidase in persistently colonized rabbits.

Authors:  Susan Sanchez; Shaikh Mizan; Charlotte Quist; Patricia Schroder; Michelle Juneau; Donald Dawe; Branson Ritchie; Margie D Lee
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

6.  Role for periodontitis in the progression of lipid deposition in an animal model.

Authors:  Ashish Jain; Eraldo L Batista; Charles Serhan; Gregory L Stahl; Thomas E Van Dyke
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.